Education
About Us
Working with TipRanks
Follow Us
Glen Clack Insider Profile
4 Followers
Glen Clack, Chief Medical Officer at Evgen Pharma, holds 3.00M shares in Evgen Pharma (Ticker: GB:TCF). Most recently, Glen Clack Bought 2,000,000p shares of Evgen Pharma on Feb 19, 2025 for an estimated value of 5.00K.
Profitable Transactions
0 out of 2 Profitable Transactions
Average Return
-48.70%
Average return per transaction
Time Frame
Compare to
Insider Roles
Chief Medical Officer
Roles that Glen Clack holds in companies
Most Profitable Insider Trade
The most profitable trade made by Glen Clack
Glen Clack's Trading History
List of latest transactions for each holding click on a transaction to see Glen Clack's performance on stock
You May Also Like
Glen Clack insider profile FAQ
What is the percentage of profitable transactions made by Glen Clack?
The percentage of profitable transactions made by Glen Clack is 0%.
What is the average return per transaction made by Glen Clack?
The average return per transaction made by Glen Clack is -48.70%.
What stocks does Glen Clack hold?
Glen Clack holds: GB:TCF stocks.
What was Glen Clack’s latest transaction?
Glen Clack latest transaction was an Informative Buy of 5.00K.
What was Glen Clack's most profitable transaction?
Glen Clack’s most profitable transaction was an Informative Buy of GB:TCF stock on February 19, 2025. The return on the trade was -21.60%.
What is Glen Clack's role in Evgen Pharma?
Glen Clack's role in Evgen Pharma is Chief Medical Officer.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.